Nrf2/Keap1/ARE signaling: Towards specific regulation

AV Ulasov, AA Rosenkranz, GP Georgiev, AS Sobolev - Life Sciences, 2022 - Elsevier
The Nrf2 transcription factor governs the expression of hundreds genes involved in cell
defense against oxidative stress, the hallmark of numerous diseases such as …

Inflammation in Parkinson's disease: mechanisms and therapeutic implications

M Pajares, A I. Rojo, G Manda, L Boscá, A Cuadrado - Cells, 2020 - mdpi.com
Parkinson's disease (PD) is a common neurodegenerative disorder primarily characterized
by the death of dopaminergic neurons that project from the substantia nigra pars compacta …

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

A Cuadrado, AI Rojo, G Wells, JD Hayes… - Nature reviews Drug …, 2019 - nature.com
The transcription factor NF-E2 p45-related factor 2 (NRF2; encoded by NFE2L2) and its
principal negative regulator, the E3 ligase adaptor Kelch-like ECH-associated protein 1 …

Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach

A Cuadrado, G Manda, A Hassan, MJ Alcaraz… - Pharmacological …, 2018 - Elsevier
Abstract Systems medicine has a mechanism-based rather than a symptom-or organ-based
approach to disease and identifies therapeutic targets in a nonhypothesis-driven manner. In …

Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates …

LE Tebay, H Robertson, ST Durant, SR Vitale… - Free Radical Biology …, 2015 - Elsevier
Abstract Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) regulates the basal and stress-
inducible expression of a battery of genes encoding key components of the glutathione …

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes

M Pajares, N Jiménez-Moreno, ÁJ García-Yagüe… - Autophagy, 2016 - Taylor & Francis
Autophagy is a highly coordinated process that is controlled at several levels including
transcriptional regulation. Here, we identify the transcription factor NFE2L2/NRF2 (nuclear …

Nrf2—a therapeutic target for the treatment of neurodegenerative diseases

DA Johnson, JA Johnson - Free Radical Biology and Medicine, 2015 - Elsevier
The brain is very sensitive to changes in redox status; thus maintaining redox homeostasis
in the brain is critical for the prevention of accumulating oxidative damage. Aging is the …

Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson's disease

I Lastres-Becker, AJ García-Yagüe… - Antioxidants & redox …, 2016 - liebertpub.com
Aims: This preclinical study was aimed at determining whether pharmacological targeting of
transcription factor NRF2, a master controller of many homeostatic genes, might provide a …

[HTML][HTML] The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease

C Zhang, M Zhao, B Wang, Z Su, B Guo, L Qin… - Redox Biology, 2021 - Elsevier
Parkinson's disease (PD) is a chronic neurodegenerative disorder that is characterized by
motor symptoms as a result of a loss of dopaminergic neurons in the substantia nigra pars …

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

G Morris, M Berk, AF Carvalho, M Maes… - Behavioural brain …, 2018 - Elsevier
Ferroptosis is a unique form of programmed death, characterised by cytosolic accumulation
of iron, lipid hydroperoxides and their metabolites, and effected by the fatal peroxidation of …